Search

Author/Creator Becerra, Carlos R.

1. A Phase 1, Open‐Label, Randomized, Crossover Study Evaluating the Bioavailability of TAS‐102 (Trifluridine/Tipiracil) Tablets Relative to an Oral Solution Containing Equivalent Amounts of Trifluridine and Tipiracil. (9th January 2017)

Authors:
Becerra, Carlos R.; Yoshida, Kenichiro; Mizuguchi, Hirokazu; Patel, Manish; Von Hoff, Daniel
Journal:
Journal of clinical pharmacology
Issue:
Volume 57:Number 6(2017)
Page Start:
751
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation. Issue 16 (14th June 2013)

Authors:
Kwak, Eunice L.; Shapiro, Geoffrey I.; Cohen, Seth M.; Becerra, Carlos R.; Lenz, Heinz‐Josef; Cheng, Wen‐Fang; Su, Wu-Chou; Robohn, Meghan; Le Maulf, Florence; Lobmeyer, Maximilian T.; Chand, Vikram K.; Iafrate, A. John
Journal:
Cancer
Issue:
Volume 119:Issue 16(2013)
Page Start:
3043
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation. Issue 16 (14th June 2013)

Authors:
Kwak, Eunice L.; Shapiro, Geoffrey I.; Cohen, Seth M.; Becerra, Carlos R.; Lenz, Heinz‐Josef; Cheng, Wen‐Fang; Su, Wu-Chou; Robohn, Meghan; Le Maulf, Florence; Lobmeyer, Maximilian T.; Chand, Vikram K.; Iafrate, A. John
Journal:
Cancer
Issue:
Volume 119:Issue 16(2013)
Page Start:
3043
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗